Article

A pilot trial of treprostinil for the treatment and prevention of digital ulcers in patients with systemic sclerosis

Stanford University, Palo Alto, California, United States
Journal of the American Academy of Dermatology (Impact Factor: 5). 06/2006; 54(5):880-2. DOI: 10.1016/j.jaad.2006.02.004
Source: PubMed

ABSTRACT We performed a pilot trial of subcutaneous treprostinil for the treatment of digital ulcers in scleroderma. Of the 5 patients completing therapy, ulcer size significantly decreased and no new ulcers occurred on continuous therapy. Although effective, the high rate of injection site reactions may limit the utility of this therapy.

0 Followers
 · 
40 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Systemic sclerosis is a connective tissue disease characterized by fibrosis of the skin, internal organs, and widespread vasculopathy. Raynaud's phenomenon and digital ulcers are vascular manifestations of this disease and cause significant morbidity. Current treatments are only moderately effective in reducing the severity of Raynaud's in a portion of patients and typically do not lead to substantial benefit in terms of the healing or prevention of digital ulcers. Several studies have evaluated the efficacy of targeting the vasoconstrictor endothelin-1 for the treatment of systemic sclerosis-associated vascular disease. The purpose of this paper is to summarize the published studies and case reports evaluating the efficacy of endothelin receptor antagonists in the treatment of Raynaud's phenomenon and digital ulcers associated with systemic sclerosis.
    International Journal of Rheumatology 10/2011; 2011:201787. DOI:10.1155/2011/201787
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Raynaud's phenomenon (RP) is characterised by transient ischaemia in the extremities in response to cold or emotions. It can be primary (idiopathic) or secondary to an underlying disease. The pathophysiology of RP is multifactorial and complex. Microvascular impairment is a hallmark of the disease. The objective of this work is to review the different pharmacological treatments currently used in the management of RP, from their mechanism of action to the available evidence regarding their efficacy. We also propose to discuss potential pharmacological targets such as the potentiation of the nitric oxide pathway, or the inhibition of the RhoA-Rho kinase pathway. The last part of this review deals with drug-induced RP. Among various medications, beta-blockers, interferons, tyrosine-kinase inhibitors or cytotoxic agents such as bleomycin are involved.
    Thérapie 03/2014; 69(2):115-128. DOI:10.2515/therapie/2013068 · 0.40 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This paper investigates a minimum spanning tree (MST) problem with fuzzy costs and quadratic cost structure, which we call the fuzzy quadratic minimum spanning tree problem (FQMST). After formulating the FQMST problem as a chance-constrained programming model based on a credibility measure, the deterministic equivalent is proposed when the fuzzy direct costs and fuzzy interactive costs are characterized by trapezoidal fuzzy numbers. Then, a genetic algorithm is designed for solving FQMST problems. Finally, a numerical example is provided for illustrating the effectiveness of the genetic algorithm.
    Fuzzy Systems, 2004. Proceedings. 2004 IEEE International Conference on; 08/2004